Table 4.
Factors Associated With Cardiovascular 3‐Year Mortality
| Factors | HR (95% CI) | P Value |
|---|---|---|
| Parameter (including only preprocedural factors) | ||
| Male sex | 1.30 (1.04–1.63) | 0.021 |
| STS score (per 1% increase) | 1.15 (1.10–1.20) | <0.001 |
| NYHA class III/IV | 1.38 (1.02–1.87) | 0.036 |
| Atrial fibrillation | 1.39 (1.11–1.74) | 0.004 |
| SVI (low flow vs normal flow) | 1.28 (1.02–1.59) | 0.033 |
| Parameter (including preprocedural and periprocedural factors) | ||
| Male sex | 1.32 (1.01–1.71) | 0.039 |
| STS score (per 1% increase) | 1.15 (1.10–1.21) | <0.001 |
| Atrial fibrillation | 1.56 (1.21–2.02) | 0.001 |
| PAD | 1.46 (1.04–2.04) | 0.029 |
| SVI (low flow vs normal flow) | 1.37 (1.06–1.77) | 0.016 |
| Aortic regurgitation ≥2 (post‐TAVI) | 1.54 (1.02–2.33) | 0.042 |
| VARC‐2 | ||
| Stroke | 1.84 (1.17–2.90) | 0.008 |
| Renal failure | 1.83 (1.36–2.47) | <0.001 |
CI indicates confidence interval; HR, hazard ratio; NYHA, New York Heart Association; PAD, peripheral artery disease; STS, Society of Thoracic Surgeons; SVI, stroke volume index; TAVI, transcatheter aortic valve implantation; and VARC, Valve Academic Research Consortium.